ImmunityBio, Inc.
US ˙ NasdaqGS ˙ US45256X1037

SecurityIBRX / ImmunityBio, Inc.
InstitutionRenaissance Technologies Llc
ManagerJames Simons
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Renaissance Technologies Llc closes position in IBRX / ImmunityBio, Inc.

On May 14, 2026 - Renaissance Technologies Llc filed a 13F-HR form disclosing ownership of 0 shares of ImmunityBio, Inc. (US:IBRX) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,231,770 shares of ImmunityBio, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F IMMUNITYBIO COM 45256X103 0 -1,231,770 -100.00 0 -100.00
2026-02-12 2025-12-31 13F IMMUNITYBIO COM 45256X103 1,231,770 215,571 21.21 2,439 -2.44 0.0038
2025-11-13 2025-09-30 13F IMMUNITYBIO COM 45256X103 1,016,199 1,016,199 2,500 0.0033
2022-11-14 2022-09-30 13F IMMUNITYBIO COM 45256X103 0 -401,681 -100.00 0 -100.00
2022-08-12 2022-06-30 13F IMMUNITYBIO COM 45256X103 401,681 401,681 1,494 0.0018
2022-05-13 2022-03-31 13F IMMUNITYBIO COM 45256X103 0 -304,900 -100.00 0 -100.00
2022-02-11 2021-12-31 13F IMMUNITYBIO COM 45256X103 304,900 96,983 46.65 1,854 -8.44 0.0023
2021-11-12 2021-09-30 13F IMMUNITYBIO COM 45256X103 207,917 207,917 2,025 0.0026
2020-11-13 2020-09-30 13F NANTKWEST COM 63016Q102 0 -32,745 -100.00 0 -100.00
2020-08-13 2020-06-30 13F NANTKWEST COM 63016Q102 32,745 -1,657,218 -98.06 402 -91.74 0.0003
2020-05-14 2020-03-31 13F NANTKWEST COM 63016Q102 1,689,963 55,038 3.37 4,867 -21.45 0.0047
2020-02-13 2019-12-31 13F NANTKWEST COM 63016Q102 1,634,925 39,200 2.46 6,196 218.23 0.0048
2019-11-13 2019-09-30 13F NANTKWEST COM 63016Q102 1,595,725 83,400 5.51 1,947 26.18 0.0016
2019-08-12 2019-06-30 13F NANTKWEST COM 63016Q102 1,512,325 280,108 22.73 1,543 -20.75 0.0014
2019-05-14 2019-03-31 13F NANTKWEST COM 63016Q102 1,232,217 155,000 14.39 1,947 55.76 0.0018
2019-02-12 2018-12-31 13F NANTKWEST COM 63016Q102 1,077,217 376,650 53.76 1,250 -51.77 0.0014
2018-11-13 2018-09-30 13F NANTKWEST COM 63016Q102 700,567 180,167 34.62 2,592 62.81 0.0027
2018-08-13 2018-06-30 13F/A-1 NANTKWEST COM 63016Q102 520,400 218,200 72.20 1,592 35.37 0.0017
2018-08-13 2018-06-30 13F NANTKWEST COM 63016Q102 302,200 1,176
2018-05-14 2018-03-31 13F NANTKWEST COM 63016Q102 302,200 69,300 29.76 1,176 12.43 0.0013
2018-02-13 2017-12-31 13F NANTKWEST COM 63016Q102 232,900 43,800 23.16 1,046 0.97 0.0012
2017-11-13 2017-09-30 13F NANTKWEST COM 63016Q102 189,100 99,700 111.52 1,036 52.58 0.0012
2017-08-11 2017-06-30 13F NANTKWEST COM 63016Q102 89,400 -396,700 -81.61 679 -60.66 0.0009
2017-05-12 2017-03-31 13F NANTKWEST COM 63016Q102 486,100 461,600 1,884.08 1,726 1,132.86 0.0024
2017-02-13 2016-12-31 13F NANTKWEST COM 63016Q102 24,500 24,500 -94.96 140 -91.89 0.0002
2016-08-12 2016-06-30 13F NANTKWEST COM 63016Q102 0 -16,700 -100.00 0 -100.00
2016-05-13 2016-03-31 13F NANTKWEST COM 63016Q102 16,700 16,700 0.00 137 0.0003
2016-02-11 2015-12-31 13F NANTKWEST COM 63016Q102 0 0 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.